Phosphodiesterase 2 as a Therapeutic Target for Heart Failure: Is Upregulation an Option?

Samuel H.H. Chan, Julie Y.H. Chan*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)13-16
Number of pages4
JournalCirculation Research
Volume120
Issue number1
DOIs
StatePublished - 06 01 2017
Externally publishedYes

Keywords

  • Editorials
  • cGMP-activated cAMP inhibition
  • heart failure
  • phosphodiesterase-2
  • sympathetic stress
  • ventricular arrhythmia

Cite this